Biotech News

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

NeuroOne Medical Technologies (NMTC)NeuroOne Medical TechnologiesEarnings

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal third quarter ended June 30, 2025, before market open on August 14, 2025.

Management will host an investor conference call and webcast at 8:30 a.m. Eastern time on Thursday, August 14, 2025, to discuss the Company’s third quarter fiscal year 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:

Third Quarter 2025 Earnings Conference Call Date: Thursday, August 14, 2025 Time: 8:30 a.m. Eastern time U.S. Dial-In (Toll Free): 888-506-0062 International Dial-In: 973-528-0011 Participant Access Code: 939482 Webcast: 3Q Webcast Link

Please join at least five minutes before the start of the call to ensure timely participation.

A playback of the call will be available through Thursday, August 28, 2025. To listen, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 52598. A webcast replay will also be available using the webcast link above through August 28, 2025.

About NeuroOne

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com .

IR Contact MZ Group – MZ North America NMTC@mzgroup.us

Related news

NeuroOne Medical Technologies

NeuroOne Medical Technologies is a medical technology company focused on neurodiagnostic and neurosurgical tools. Its products are aimed at improving procedures and monitoring in the neurology and epilepsy workflow.

Recent company news

Stock data

Close
2.15 USD
Market cap
30.69M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States